Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Langley

Showing results (31-40 of 333) with videos related to

Pageof 34
Sort By:
The American Journal of Managed Care|September 8, 2000
Is cost effectiveness modeling useful?P C Langley
Innovations in Pharmacy|January 19, 2023
Mapping Impossible Utilities: The ICER Report on Tezepelumab for Severe AsthmaPaul C Langley
Innovations in Pharmacy|May 23, 2022
Abandoning Eugenics and the QALYPaul C Langley
Innovations in Pharmacy|March 15, 2024
Rejecting False Claims from Markov Simulations in Alzheimer's DiseasePaul C Langley
The Economic Record|January 1, 1977
Inter-regional migration and economic opportunity, Australia, 1966-71P C Langley
Innovations in Pharmacy|May 19, 2021
A Practice Based Chronic Pain Management Registry (CPMR): Structure and Content of Proposed Patient and Patient/Provider PlatformsPaul C Langley
Innovations in Pharmacy|May 19, 2021
A Practice Based Behavioral Health Management Registry (BHMR): Implementation, Structure and ContentPaul C Langley
Innovations in Pharmacy|May 19, 2021
The Imaginary Worlds of Cure Proportion Modeling: Survivorship and Reference Case Pricing of Transformative TherapiesPaul C Langley
Innovations in Pharmacy|May 19, 2021
More Unnecessary Imaginary Worlds - Part 4: The ICER Evidence Report for Crizanlizumab, Voxelotor and L-Glutamine for Sickle Cell DiseasePaul C Langley
Innovations in Pharmacy|May 19, 2021
Value Assessment, Real World Evidence and Fundamental Measurement: Version 3.0 of the Minnesota Formulary Submission GuidelinesPaul C Langley
Pageof 34

Showing results (31-40 of 333) with videos related to

Sort By:
Pageof 34
The American Journal of Managed Care|September 8, 2000
Is cost effectiveness modeling useful?P C Langley
Innovations in Pharmacy|January 19, 2023
Mapping Impossible Utilities: The ICER Report on Tezepelumab for Severe AsthmaPaul C Langley
Innovations in Pharmacy|May 23, 2022
Abandoning Eugenics and the QALYPaul C Langley
Innovations in Pharmacy|March 15, 2024
Rejecting False Claims from Markov Simulations in Alzheimer's DiseasePaul C Langley
The Economic Record|January 1, 1977
Inter-regional migration and economic opportunity, Australia, 1966-71P C Langley
Innovations in Pharmacy|May 19, 2021
A Practice Based Chronic Pain Management Registry (CPMR): Structure and Content of Proposed Patient and Patient/Provider PlatformsPaul C Langley
Innovations in Pharmacy|May 19, 2021
A Practice Based Behavioral Health Management Registry (BHMR): Implementation, Structure and ContentPaul C Langley
Innovations in Pharmacy|May 19, 2021
The Imaginary Worlds of Cure Proportion Modeling: Survivorship and Reference Case Pricing of Transformative TherapiesPaul C Langley
Innovations in Pharmacy|May 19, 2021
More Unnecessary Imaginary Worlds - Part 4: The ICER Evidence Report for Crizanlizumab, Voxelotor and L-Glutamine for Sickle Cell DiseasePaul C Langley
Innovations in Pharmacy|May 19, 2021
Value Assessment, Real World Evidence and Fundamental Measurement: Version 3.0 of the Minnesota Formulary Submission GuidelinesPaul C Langley
Pageof 34